Department for Emerging Pathogens and Vaccines, John Curtin School of Medical Research, Canberra, Australia.
PLoS One. 2011;6(8):e23252. doi: 10.1371/journal.pone.0023252. Epub 2011 Aug 11.
NK cells kill target cells mainly via exocytosis of granules containing perforin (perf) and granzymes (gzm). In vitro, gzm delivery into the target cell cytosol results in apoptosis, and induction of apoptosis is severely impaired in the absence of gzm A and B. However, their importance for in vivo cytotoxicity by cytotoxic T cells has been questioned. We used an in vivo NK cytotoxicity assay, in which splenocytes from wild-type and β(2)microglobulin-deficient (MHC-I(neg)) mice are co-injected into recipients whose NK cells were activated by virus infection or synthetic Toll-like receptor ligands. Elimination of adoptively transferred MHC-I(neg) splenocytes was unimpaired in the absence of gzmA and gzmB, but dependent on perforin. This target cell rejection was NK cell dependent, since NK cell depletion abrogated it. Furthermore, target cell elimination in vivo was equally rapid in both wild-type and gzmAxB-deficient recipients, with the majority of specific target cells lost from lymphoid tissue within less than one to two hours after transfer. Thus, similar to T cell cytotoxicity, the contribution of gzmA and B to in vivo target cell elimination remains unresolved.
NK 细胞主要通过含有穿孔素 (perf) 和颗粒酶 (gzm) 的颗粒的胞吐作用来杀死靶细胞。在体外,gzm 递送到靶细胞胞质溶胶中会导致细胞凋亡,并且在没有 gzm A 和 B 的情况下,细胞凋亡的诱导严重受损。然而,它们对细胞毒性 T 细胞体内细胞毒性的重要性一直存在争议。我们使用了一种体内 NK 细胞毒性测定法,其中来自野生型和 β(2)微球蛋白缺陷 (MHC-I(neg)) 小鼠的脾细胞被共同注射到 NK 细胞被病毒感染或合成 Toll 样受体配体激活的受体中。在缺乏 gzmA 和 gzmB 的情况下,对同种型转移的 MHC-I(neg) 脾细胞的消除没有受到影响,但依赖于穿孔素。这种靶细胞排斥是 NK 细胞依赖性的,因为 NK 细胞耗竭会消除它。此外,在体内,靶细胞的消除在野生型和 gzmAxB 缺陷型受体中同样迅速,大多数特异性靶细胞在转移后不到一到两个小时内从淋巴组织中丢失。因此,与 T 细胞细胞毒性类似,gzmA 和 B 对体内靶细胞消除的贡献仍未解决。